HomeSearchHematological Oncology

Hematological Oncology

John Wiley and Sons Ltd · United Kingdom · Est. 1963

ISSN1099-1069
SJR Q1WOS SCIEScopus / SJR
Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

📊 Standing in its field
Where this journal ranks among others in the same subject area.
Q1
SJR · Scopus
Top 25% in field
Clarivate’s JCR quartile is a separate ranking and may differ
SJR Scorei
1.073
H-Indexi
72
SNIPi
0.838
Total Worksi
5,990
Total Citationsi
40,927
2yr Mean Citednessi
0.45
Open Impact Factor alternative
Retractions
3
Source: Retraction Watch

Aims & Scope

Subject areas: Hematology; Oncology; Medicine (miscellaneous); Cancer Research.

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1963
Frequency4 No. A Year, 1996-
StatusActive (last: 2026)
Total Publications5,990
Publisher OrgWiley
Visit Journal Website

Submission Info

Peer Review
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

6/11 · 55%
Do you know the journal / publisher?
John Wiley and Sons Ltd
Does the journal have a website?
✓ Linked
Is the ISSN verified?
1099-1069
Indexed in a trusted database?
WoS, Scopus
Peer review process documented?
N/A
Follows ethical publishing standards (COPE)?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
699
4.1k
2019
137
1.5k
2020
531
2k
2021
167
1.4k
2022
836
1.7k
2023
106
312
2024
1.1k
442
2025
83
9
2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

HematologyQ1
Medicine (miscellaneous)Q1
Cancer ResearchQ2
OncologyQ2

Subject Classification

Web of Science Categories

HematologyOncology

Scopus Categories

HematologyCancer ResearchOncologyMedicine (miscellaneous)

Research Topics (OpenAlex)

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchCAR-T cell therapy researchCNS Lymphoma Diagnosis and TreatmentViral-associated cancers and disordersAcute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchLung Cancer Treatments and MutationsChronic Myeloid Leukemia TreatmentsMultiple Myeloma Research and Treatments

Frequently asked questions about Hematological Oncology

Is Hematological Oncology a predatory journal?

PubScope has no integrity flags on record for Hematological Oncology: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Hematological Oncology?

Hematological Oncology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 0.45.

Is Hematological Oncology indexed in Scopus and Web of Science?

Hematological Oncology is indexed in Web of Science, Scopus.

What is the aims and scope of Hematological Oncology?

Subject areas: Hematology; Oncology; Medicine (miscellaneous); Cancer Research.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref